{"id":390717,"date":"2018-03-29T00:00:00","date_gmt":"2018-03-29T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/unneim0009-2018-biopharma-ulcerative-colitis-unmet-need-us-eu-2018\/"},"modified":"2026-05-03T23:38:29","modified_gmt":"2026-05-03T23:38:29","slug":"unneim0009-2018-biopharma-ulcerative-colitis-unmet-need-us-eu-2018","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/unneim0009-2018-biopharma-ulcerative-colitis-unmet-need-us-eu-2018\/","title":{"rendered":"Ulcerative Colitis | Unmet Need | US\/EU | 2018"},"content":{"rendered":"<p><strong>MARKET OUTLOOK<\/strong><\/p>\n<p><strong>QUESTIONS ANSWERED<\/strong><\/p>\n<ul>\n<li>What are the treatment drivers and goals for [[indication]]?<\/li>\n<li>What drug attributes are key influencers, which have limited impact, and which are hidden opportunities?<\/li>\n<li>How do current therapies perform on key treatment drivers and goals for [[indication]]?<\/li>\n<li>What are the prevailing areas of unmet need and opportunity in [[indication]]?<\/li>\n<li>What trade-offs across different clinical attributes and price are acceptable to U.S. and European [[physician type, plural]] for a hypothetical new [[indication]] drug?<\/li>\n<\/ul>\n<p><strong>PRODUCT DESCRIPTION<\/strong><\/p>\n<p>Provides quantitative insight into U.S. and European physician perceptions of key treatment drivers and goals and the current level of unmet need for a specific disease. Commercial opportunities are analyzed, and the extent to which emerging therapies may capitalize on these opportunities is evaluated.<\/p>\n<p><strong>Markets covered:<\/strong>\u00a0United States, United Kingdom, France, Germany<\/p>\n<p><strong>Primary research:\u00a0<\/strong>Survey of [[XX]] U.S. and [[XX]] European [[physician type, plural]] fielded in [[Month. Year]]<\/p>\n<p><strong>Key companies:<\/strong>\u00a0[[key company 1]], [[key company 2]], [[key company 3]]<\/p>\n<p><strong>Key drugs:<\/strong>\u00a0[[key drug 1]], [[key drug 2]], [[key drug 3]]<\/p>\n","protected":false},"template":"","class_list":["post-390717","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-ulcerative-colitis","biopharma-product-unmet-need","biopharma-geography-us","biopharma-date-920"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/390717","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/390717\/revisions"}],"predecessor-version":[{"id":393841,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/390717\/revisions\/393841"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=390717"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}